KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Accumulated Expenses (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Accumulated Expenses for 7 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 15.99% year-over-year to $16.0 million, compared with a TTM value of $16.0 million through Dec 2025, down 15.99%, and an annual FY2025 reading of $16.0 million, down 15.99% over the prior year.
  • Accumulated Expenses was $16.0 million for Q4 2025 at Clover Health Investments, down from $17.2 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $35.3 million in Q3 2024 and bottomed at $10.2 million in Q2 2021.
  • Average Accumulated Expenses over 5 years is $20.9 million, with a median of $19.6 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses surged 24038.09% in 2021, then plummeted 51.41% in 2025.
  • Year by year, Accumulated Expenses stood at $15.1 million in 2021, then skyrocketed by 58.2% to $24.0 million in 2022, then dropped by 12.57% to $21.0 million in 2023, then fell by 8.88% to $19.1 million in 2024, then dropped by 15.99% to $16.0 million in 2025.
  • Business Quant data shows Accumulated Expenses for CLOV at $16.0 million in Q4 2025, $17.2 million in Q3 2025, and $25.2 million in Q2 2025.